17K BMRN shares were withheld to cover taxes or exercise cost (CEO) | OQRO Insider tradesWhy it stands out
Routine share withholding; mechanical by default.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Dec 1, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Dec 2, 2025
CEOTax withholding
Context
- Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
- Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001628280-25-054856
Filed / recordedDec 2, 2025, 11:29 PM UTCAdded to OQROOct 6, 2026, 4:40 PM UTC Data qualityVerified: identifiers matched exactly IssuerBIOMARIN PHARMACEUTICAL INC Reporting personAlexander Hardy RelationshipDirector, Officer Officer titleChief Executive Officer TableNon-derivative (Table I) Transaction dateDec 1, 2025 Acquired / disposedDisposed (D) Shares owned after159,388 Around the same time
Traded Apr 30, 2025 · filed 216 days later
Compensation award — excluded from discretionary-purchase analysis.